If you are attending, find Carmen at poster 276 on 14 and 15 October.
#ELRIGDD26 #ELRIGDD26 #DrugDiscovery #TripleNegativeBreastCancer #NaturalProducts #3DCellModels #MachineLearning

If you are attending, find Carmen at poster 276 on 14 and 15 October.
#ELRIGDD26 #ELRIGDD26 #DrugDiscovery #TripleNegativeBreastCancer #NaturalProducts #3DCellModels #MachineLearning
Metabolic disease rarely affects only one organ. So how do you capture a therapy's effects beyond its target organ in trial design?
Thursday 15 October, #ELRIGDD26: Anna Veprik presents how multi-organ MR imaging can be used as a precision biomarker in drug discovery.
We also looked ahead to the future of AI, the changing needs of scientific professionals, and what the next 20 years could bring.
🎥 Watch our full interview: youtu.be/xIbgXVyGrNw
Register for Drug Discovery 2026: elrig.org/portfolio/dr...